What problem is Axon trying to solve?

Axon targets the overwhelming complexity of clinical workflows. According to slides 3 and 4, medical teams are burdened by 178 tasks and 700 potential clinical pathways. The deck suggests that current communication often happens over insecure channels like WhatsApp (Slide 5), which creates risks for patient data and hospital efficiency.

Who are the founders of Axon?

The leadership team consists of Dr. Chandrashan Perera (CEO), Dr. Paul Paddle (CMO), Sanji Kanagalingam (COO), and Julian Kelabora (CTO). Having two doctors in the C-suite suggests the company is built on deep clinical insight rather than just technical capability.

What is Axon's geographic expansion strategy?

As shown on Slide 7, the company started with a departmental approach in 2016, aiming for broader Australian hospital adoption in 2017. They planned to enter the US hospital market in 2018 and achieve international scale by 2019.

Does the deck show a working product?

The deck shows a conceptual mockup of a mobile notification on Slide 5, but it does not provide a detailed walkthrough of a proprietary interface. It uses a blurred WhatsApp message to demonstrate the 'current state' of hospital communication rather than the 'future state' of the Axon product.

What financial information is included in the pitch?

The provided slides contain no financial information. There are no mentions of revenue, burn rate, customer acquisition costs, or the size of the investment they are seeking. It is a purely narrative and vision-based Demo Day deck.

Axon Pitch Deck: 14-Slide Breakdown

See all 14 slides of the Axon pitch deck, with a slide-by-slide teardown of what the deck does well and where it falls short.

Axon’s MAP16 Demo Day deck is a minimalist, visual-heavy presentation designed to highlight the operational inefficiencies within hospital environments. By quantifying the '178 tasks' and '700 possible clinical pathways' involved in patient care, the deck establishes a clear problem of complexity. The solution is hinted at through a mobile interface mockup showing clinical communication via WhatsApp, suggesting a need for a more formal, secure alternative. While the deck succeeds in problem identification and showcases a team with strong medical credentials, it lacks critical financial data,…

Key takeaways

The deck identifies a high-friction environment where a single medical team manages 178 discrete tasks for a patient (Slide 3).
Complexity is further emphasized by the claim of 700 possible clinical pathways between staff and patients (Slide 4).
The current 'shadow IT' problem is illustrated with a WhatsApp notification mockup regarding a wound photo and antibiotic request (Slide 5).
The founding team features two medical doctors, including Dr. Chandrashan Perera (CEO) and Dr. Paul Paddle (CMO), providing high domain authority (Slide 6).
The roadmap targets a transition from a 'Hospital Departmental Approach' in 2016 to full 'International' expansion by 2019 (Slide 7).
Early traction is indicated by the presence of Austin Health and Monash Health logos on the roadmap slide (Slide 7).
The deck completely omits a business model, pricing strategy, or competitive analysis within the provided slides.
There is no specific funding 'Ask' or breakdown of how capital would be deployed to reach the 2019 international goal.

Slide-by-Slide Analysis

Slide 1: Title Slide

The deck opens with a minimalist dark grey background featuring the company name 'AXON' in white, sans-serif capital letters. A small, dashed green line sits beneath the text. There is no tagline, industry categorization, or date. This is a standard 'blind' title slide common in high-pressure Demo Day environments where the speaker provides the context verbally.

Slide 2: The Persona

This slide contains only a single icon of a doctor in a blue coat with a stethoscope. There is no text. In a live pitch, this slide likely serves as the introduction to the 'user' or 'customer' profile, establishing the human element of the healthcare problem before moving into data-heavy slides.

Slide 3: Task Volume

Axon begins to quantify the problem here. The slide shows a medical team (one lead doctor and four staff icons) on the left, an arrow pointing to a central green box, and a patient icon on the right. The central box contains the figure '178 TASKS' and is surrounded by dozens of clipboard icons. This slide effectively visualizes the administrative and clinical burden placed on a single team for a single patient interaction.

Slide 4: Pathway Complexity

Building on the previous slide, this visual replaces the tasks with '700 POSSIBLE CLINICAL PATHWAYS.' The background of the central box is filled with a chaotic web of colored lines (blue, green, red) connecting the medical team to the patient. This slide is designed to provoke a sense of 'complexity fatigue' in the audience, justifying the need for a software solution to manage these variables.

Slide 5: The Status Quo (Shadow IT)

This slide features a smartphone lock screen mockup. It shows two WhatsApp notifications. The text in the notification reads: 'Here is a wound photo from Mr. [Name Blurred] in Bed 22. Should he have antibiotics?' The use of WhatsApp—a consumer messaging app—in a clinical setting highlights a major compliance and security gap. It implies that because official systems are too complex, doctors resort to insecure, informal tools to get work done.

Slide 6: The Team

The team slide introduces four key members: Dr. Chandrashan Perera (CEO) , Dr. Paul Paddle (CMO) , Sanji Kanagalingam (COO) , and Julian Kelabora (CTO) . The inclusion of two medical doctors (CEO and CMO) is a significant credibility marker for a HealthTech startup, suggesting the product is designed by practitioners who understand the 700 pathways mentioned earlier.

Slide 7: Roadmap and Traction

The final slide in this set is a horizontal timeline. It lists two partner logos at the top left: Austin Health and Monash Health . The timeline outlines the following goals:

2016: Hospital Departmental Approach · 2017: Australian Hospitals · 2018: US Hospitals · 2019: International

This slide serves as both a traction proof-point (via the hospital logos) and a growth projection, though it lacks specific metrics for what 'International' or 'US Hospitals' entails in terms of seat count or revenue.

What Axon Does Well

Axon excels at visual storytelling . Instead of using bulleted lists to describe hospital inefficiency, they use specific numbers—178 and 700—to anchor the scale of the problem. The transition from Slide 3 to Slide 4 creates a logical escalation: first, there are too many tasks; second, the relationship between those tasks is too complex to manage manually.

The 'WhatsApp Slide' (Slide 5) is a masterclass in identifying a 'hair-on-fire' problem. Every hospital administrator knows that staff use personal messaging apps for clinical work, creating massive legal and security liabilities. By showing a real-world (albeit blurred) example of a doctor asking for antibiotic orders over WhatsApp, Axon makes the risk visceral to the investor.

Finally, the Team Slide is balanced. Having a CEO who is also a doctor (Dr. Chandrashan Perera) reduces the 'founder-market fit' risk that often plagues tech-heavy healthcare startups. The presence of a dedicated CTO and COO suggests the company has the operational and technical scaffolding to support the medical vision.

What Is Missing from the Deck

As a Demo Day pitch, this deck is intentionally light on text, but it leaves several critical investor questions unanswered. Most notably, there is no Business Model slide . It is unclear if Axon is a SaaS platform charging per clinician, a per-bed enterprise license, or a value-based care play. Without knowing how they capture value from the '700 pathways,' it is difficult to assess the venture's scalability.

There is also a complete absence of competitive analysis . The clinical communication space is crowded with players like Epic (Canto/Haiku), TigerConnect, and Vocera. Axon does not explain how its 'pathway' approach differs from these established incumbents or how they plan to integrate with existing Electronic Health Records (EHR) systems.

The Ask is missing . While this may have been delivered verbally or on a final slide not included in this set, a teardown must note that the capital requirement is not stated. An investor doesn't know if they are raising $500k for a pilot or $5M for the US expansion mentioned in the roadmap.

Lessons for Founders

1. Use 'Anchor Numbers' for Problem Slides: Axon didn't just say 'hospitals are busy.' They said there are '178 tasks.' Specificity creates authority. When pitching a complex industry, find a metric that represents the friction you are solving and make it the centerpiece of your slide.

2. Show the 'Dirty' Reality: Slide 5 (the WhatsApp notification) is effective because it shows the 'workaround' users have created. If your target customers are using a broken or insecure tool to solve a problem, show a screenshot of that tool. It proves that the demand for a solution already exists, even if the current solution is suboptimal.

3. Roadmap Alignment: Axon’s roadmap (Slide 7) is clean and follows a logical geographic progression. However, founders should ensure that their traction (the logos at the top) matches the current stage of the roadmap. Axon successfully places Austin Health and Monash Health next to the 2016 'Departmental' phase, which validates their starting point.

4. Iconography over Text: For a stage presentation, less is more. Axon’s use of simple icons for doctors and patients allows the audience to listen to the speaker rather than reading the screen. If you are designing a deck for a live pitch, aim for the 'one big idea per slide' rule demonstrated here.

Frequently asked questions

What problem is Axon trying to solve?: Axon targets the overwhelming complexity of clinical workflows. According to slides 3 and 4, medical teams are burdened by 178 tasks and 700 potential clinical pathways. The deck suggests that current communication often happens over insecure channels like WhatsApp (Slide 5), which creates risks for patient data and hospital efficiency.
Who are the founders of Axon?: The leadership team consists of Dr. Chandrashan Perera (CEO), Dr. Paul Paddle (CMO), Sanji Kanagalingam (COO), and Julian Kelabora (CTO). Having two doctors in the C-suite suggests the company is built on deep clinical insight rather than just technical capability.
What is Axon's geographic expansion strategy?: As shown on Slide 7, the company started with a departmental approach in 2016, aiming for broader Australian hospital adoption in 2017. They planned to enter the US hospital market in 2018 and achieve international scale by 2019.
Does the deck show a working product?: The deck shows a conceptual mockup of a mobile notification on Slide 5, but it does not provide a detailed walkthrough of a proprietary interface. It uses a blurred WhatsApp message to demonstrate the 'current state' of hospital communication rather than the 'future state' of the Axon product.
What financial information is included in the pitch?: The provided slides contain no financial information. There are no mentions of revenue, burn rate, customer acquisition costs, or the size of the investment they are seeking. It is a purely narrative and vision-based Demo Day deck.

Cover slide of the Axon pitch deck — Axon pitch deck, slide 1

Axon pitch deck: the facts

Company: Axon
Slides: 14

Axon pitch deck PDF

The full Axon deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Axon pitch deck was used for

This deck is the **Axon – MAP16 Demo Day Pitch** used in the 2016 cohort of the Melbourne Accelerator Program (MAP) and hosted on Slideshare as a 14‑slide presentation. Axon is described by MAP as “connections in health,” and the deck (per the existing excerpt) focuses on friction in hospital communication and clinical decision‑making, emphasizing the volume of tasks and pathways that medical staff must manage. The presentation appears to position Axon as a healthcare communication solution aimed at reducing medical errors and improving clinical workflows, pitched at an accelerator demo day rather than a clearly documented priced funding round. No credible external sources link this specific demo‑day pitch to a disclosed investment amount, valuation, or investor group.

What the Axon deck got right

Strong visual communication of hospital workflow friction. The deck’s use of **high‑level iconography and visual depiction of hospital workflows** effectively conveys the complexity and friction in clinical communication, making the problem intuitive for both clinical and non‑clinical investors.
Clear articulation of clinical workload and risk context. By focusing on the **sheer volume of tasks and pathways managed by medical staff**, the deck frames the problem in terms of cognitive load and process risk, which supports a compelling narrative around medical errors and the need for better tools.
Association with a reputable accelerator program. Positioning Axon as “**connections in health**” within the Melbourne Accelerator Program cohort aligns it with a recognizable accelerator brand and signals a curated selection process, which can add credibility with early‑stage investors.
Ambitious international expansion vision. The inclusion of a **roadmap for international expansion** shows ambition and a vision beyond local deployment, which can appeal to investors looking for scalable health‑tech opportunities.
Concise demo‑day narrative structure. The deck appears to be targeted at a **demo‑day audience**, which typically forces concise messaging and a focused narrative on the problem and proposed solution, helping maintain clarity and pacing for investors.

What could have been stronger

Lack of externally verified traction linked to the deck. Externally, there is no accessible evidence of **traction metrics** (such as number of hospitals using the product, reduction in medical errors, or revenue) tied to this deck, which likely makes it harder for investors to assess real‑world validation from the demo‑day pitch alone.
Business model not clearly evidenced in public materials. Public descriptions of the deck emphasize iconography and high‑level illustrations of hospital workflow friction but do not surface a clearly articulated **business model** (pricing, buyer, sales cycle) that investors could evaluate.
Limited visibility into regulatory and integration strategy. Although the existing excerpt mentions a roadmap for international expansion, there is no externally available detail on **regulatory strategy, data privacy, or clinical integration** plans, which are critical concerns for a hospital‑focused health tech product.
Team background not visible from available context. No external sources for this specific deck identify the **founding team’s credentials** or prior experience in healthcare, clinical practice, or health IT, reducing investors’ ability to assess team‑market fit based on publicly available information.

How an investor would read this deck

What draws attention

Clarify Axon’s **core product**: is it a communication platform, checklist system, clinical decision support tool, or a combination, and what exact workflows in hospitals it targets.
Understand the **problem severity** Axon is tackling (e.g., specific types of medical errors, communication delays) and how it quantifiably improves clinical decision‑making compared to current hospital practices.
Assess the **implementation model** in hospitals (pilot deployments, integration with existing systems, training requirements) and any early partnerships, since the deck appears to focus on friction but not externally documented rollouts.
Evaluate the claimed **international expansion roadmap** in light of regulatory requirements and go‑to‑market capabilities in different healthcare systems.

Risks that stand out

Hospital IT and clinical workflow tools face **long sales cycles** and complex stakeholder environments; the absence of externally verified traction connected to this deck increases the risk that Axon might struggle with adoption.
Healthcare communication and workflow solutions operate in a **crowded and regulated space**, and without clear public differentiation or regulatory strategy, Axon may face competitive and compliance challenges.
If Axon’s roadmap for international expansion is ambitious without matching resources or partnerships, there is execution risk in scaling across different healthcare systems and regulations.
Limited publicly visible information about the team and funding history tied to this specific deck makes it harder to assess whether Axon has the expertise and capital needed to navigate hospital procurement and clinical integration.

Questions this deck invites

What specific hospital communication or clinical workflows does Axon’s product support, and how does it technically integrate with existing hospital IT systems (e.g., EMRs, paging, secure messaging)?
Has Axon conducted pilots or deployments in hospitals, and can it provide data on error reduction, time savings, or improved patient outcomes resulting from its solution?
What is Axon’s revenue model (e.g., per‑bed SaaS, per‑hospital license, per‑user subscription) and how long is the expected sales cycle with hospital customers?
How does Axon address regulatory and compliance requirements (e.g., data protection, clinical risk management) in the jurisdictions targeted in its international expansion roadmap?
Who are Axon’s direct competitors in hospital communication and workflow tools, and what differentiated capabilities does Axon offer (e.g., checklists, decision support, analytics)?

What founders can take from the Axon deck

Demo‑day decks that rely heavily on **iconography and process visuals** can communicate complex clinical workflows and friction effectively, but they should be paired with clear, externally verifiable traction metrics to strengthen investor confidence.
In health‑tech pitches focusing on hospital communication, explicitly connecting the **workflow problem** to measurable outcomes such as error reduction or mortality improvements makes the narrative more compelling to investors.
Including a **roadmap for international expansion** signals ambition, but investors need supporting details on regulatory, integration, and go‑to‑market strategies; otherwise the expansion story risks appearing aspirational rather than executable.
Brief external descriptors like “**connections in health**” are useful as a tagline, but pitch decks benefit from more explicit product definitions that distinguish between communication platforms, checklists, and decision‑support tools.
Accelerator demo‑day decks often prioritize storytelling and high‑level friction over hard numbers; for fundraising beyond demo day, founders need to evolve these decks with **validated metrics, customer references, and clearer business models**.
Using hospital workflow diagrams and task volumes to show the **cognitive load on clinicians** can make the problem vivid, but founders should also show how their solution fits into these workflows without adding new burdens to staff.

Axon pitch deck: common questions

What does Axon do in this MAP16 Demo Day pitch deck?

Axon is described by the Melbourne Accelerator Program (MAP) as a startup focused on **“connections in health,”** and the demo‑day pitch deck (as summarized in the existing excerpt) highlights friction in hospital communication and clinical decision‑making, suggesting a product around improving clinical communication and workflow in hospitals.

What is the context of Axon’s MAP16 Demo Day pitch deck?

The deck was used for the **MAP16 Demo Day Pitch** associated with the Melbourne Accelerator Program’s 2016 cohort and is hosted on Slideshare with 14 slides. It appears to be an accelerator demo‑day presentation rather than a disclosed priced funding round deck.

Which investors funded Axon based on this demo‑day pitch?

Public information tied specifically to this Slideshare deck does not identify named investors, a closed round, or funding amount associated with the MAP16 Demo Day pitch, and no credible funding announcement could be linked directly to Axon in this context.

How many slides are in Axon’s MAP16 Demo Day pitch deck and what does it focus on?

The deck is a **14‑slide** presentation hosted on Slideshare under the title “Axon – MAP16 Demo Day Pitch.” OCR from the deck is largely unreadable, but external description indicates that Axon uses iconography and process visuals to illustrate hospital communication friction and a roadmap for international expansion.

What is known externally about Axon from the MAP16 cohort listing?

MAP lists Axon among ten startups in its 2016 cohort and describes it briefly as **“connections in health.”** No further externally verified data on Axon’s later corporate development, funding, or product launch tied specifically to this demo‑day pitch could be found.